Genetic markers of chronic lymphocytic leukemia: a retrospective study of 312 patients from a reference center in Lebanon

Future Oncol. 2023 Sep;19(29):1991-2002. doi: 10.2217/fon-2023-0535. Epub 2023 Oct 5.

Abstract

Aim: Chronic lymphocytic leukemia (CLL) is a highly heterogenous hemopathy. Genetic stratification of CLL patients has important prognostic and therapeutic values - mainly immunoglobulin heavy chain variable region gene (IGHV) mutational status and the presence of cytogenetic abnormalities. The genetics of CLL in Lebanon is scarcely described in the literature. Patients & methods: In this work, we studied the genetic biomarkers of 312 Lebanese CLL patients. Results: Prominent IGHV genes were IGHV4-34, IGHV1-69 and IGHV3-30; and CLL #1 and #5 presented major subsets. Some similarities as well as major differences were highlighted when comparing our data with previously published data. Conclusion: The distribution of IGHV alleles in our series differed from previously described distributions, suggesting involvement of antigenic selection and regional variables in CLL pathogenesis.

Keywords: CLL; FISH; IGHV; Lebanon; biomarkers; chronic lymphocytic leukemia; cytogenetics; karyotype; molecular diagnosis.

MeSH terms

  • Genes, Immunoglobulin Heavy Chain / genetics
  • Genetic Markers
  • Humans
  • Immunoglobulin Variable Region / genetics
  • Lebanon / epidemiology
  • Leukemia, Lymphocytic, Chronic, B-Cell* / diagnosis
  • Leukemia, Lymphocytic, Chronic, B-Cell* / epidemiology
  • Leukemia, Lymphocytic, Chronic, B-Cell* / genetics
  • Mutation
  • Prognosis
  • Retrospective Studies

Substances

  • Genetic Markers
  • Immunoglobulin Variable Region